From the Clinic of General Surgery and Surgical Oncology.
Department of Plastic Surgery and Burns, Hospital in Nowa Sol.
Plast Reconstr Surg. 2023 Jun 1;151(6):1123-1133. doi: 10.1097/PRS.0000000000010110. Epub 2022 Dec 26.
Breast cancer remains the most common nonskin cancer among women. Prophylactic methods for reducing surgical-site complications after immediate breast reconstruction (IBR) are crucial to prevent acellular dermal matrices or prosthesis exposure and loss. The authors assessed the impact of closed-incision negative-pressure wound therapy (ciNPWT) versus standard dressings (ST) after IBR on surgical-site complications, superficial skin temperature (SST), skin elasticity, and subjective scar quality, to determine the potential benefit of prophylactic ciNPWT application.
A multicenter randomized controlled study of 60 adult female patients was conducted between January of 2019 and July of 2021. All patients had oncologic indications for IBR using implants or expanders.
Application of ciNPWT correlated with a significant decrease in surgical-site complications within 1 year of surgery (total, 40%; ST, 60%; ciNPWT, 20%; P = 0.003) and resulted in more elastic scar tissue as measured with a Cutometer (average coefficient of elasticity, 0.74; ST, 0.7; ciNPWT, 0.9; P < 0.001). The SST of each scar 1 week after surgery was significantly higher in the ciNPWT group (average SST, 31.5; ST SST, 31.2; ciNPWT SST, 32.3; P = 0.006). According to the Patient and Observer Scar Assessment Scale v2.0, subjective scar outcomes in both groups were comparable.
This is the first randomized controlled study that demonstrated a significant decrease in surgical-site wound complications within 1 year of surgery in IBR patients receiving ciNPWT. A high probability of postoperative radiotherapy should be a relative indication for the use of ciNPWT. .
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
乳腺癌仍然是女性中最常见的非皮肤癌。预防即刻乳房重建(IBR)后手术部位并发症的方法对于防止脱细胞真皮基质或假体暴露和丢失至关重要。作者评估了 IBR 后闭合切口负压伤口治疗(ciNPWT)与标准敷料(ST)对手术部位并发症、浅表皮肤温度(SST)、皮肤弹性和主观瘢痕质量的影响,以确定预防性 ciNPWT 应用的潜在益处。
2019 年 1 月至 2021 年 7 月进行了一项多中心随机对照研究,共纳入 60 例成年女性患者,均有接受 IBR 手术的肿瘤学指征,使用植入物或扩张器。
ciNPWT 的应用与术后 1 年内手术部位并发症显著减少相关(总并发症率:40%;ST 组:60%;ciNPWT 组:20%;P = 0.003),并且使用 Cutometer 测量的瘢痕组织弹性更高(平均弹性系数:0.74;ST 组:0.7;ciNPWT 组:0.9;P < 0.001)。ciNPWT 组术后 1 周时每个瘢痕的 SST 均显著升高(平均 SST:31.5;ST SST:31.2;ciNPWT SST:32.3;P = 0.006)。根据第 2.0 版患者和观察者瘢痕评估量表,两组的主观瘢痕结果相当。
这是第一项随机对照研究,证明 IBR 患者接受 ciNPWT 治疗后,术后 1 年内手术部位伤口并发症显著减少。术后放疗的高概率应成为使用 ciNPWT 的相对指征。
临床问题/证据水平:治疗性,II 级。